Login Register Cart 0
Generic placeholder image

Current Nanomedicine

Editor-in-Chief

ISSN (Print): 2468-1873
ISSN (Online): 2468-1881

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Nanosuspension as a Novel Nanovehicle for Drug Delivery: A Recent Update on Patents and Therapeutic Applications

Author(s): Asha Rani, Ravinder Verma, Manish Kumar, Abhishek Tiwari, Varsha Tiwari, Shailendra Bhatt, Vineet Mittal and Deepak Kaushik*

Volume 14, Issue 2, 2024

Published on: 01 November, 2023

Page: [88 - 98] Pages: 11

DOI: 10.2174/0124681873270131231023082115

Price: $65

Abstract

Solubility is a critical factor for the therapeutic action of drugs and does not depend on the administration of routes. Various conventional methods are used to enhance the solubility of the drug, which show limited applicability. Nanotechnology is used to improve the solubility and bioavailability of drugs that belong to BCS classes II and IV. Nanosuspension is the dispersion of pure drug nanoparticles in aqueous with a minimum amount of surfactant, stabilizing the formulation. Various techniques, such as the bottom-up approach, dissocubes, nanopure, nanoedge, nanojet process, supercritical fluid, dry co-grinding, milling media, and nanoprecipitation, have been used to formulate nanosuspension. Nanosuspension can be administered orally, inhalation, transdermal, ocular, injectable, topical, and pulmonary. To resolve the problem of solubility and stability, nanosuspension has received much attention because of its technical simplicity, costeffectiveness, and ease of significant scale-up. Nanosuspension can control particle size surface charge properties and release the drug at specific sites at an optimal rate. Recently, more than 100 patents have been published on nanosuspension. This review article covers the different preparation methods, formulation composition, marketed products, characterization, and recent patents on nanosuspension. The various benefits and evaluation of the parameters of nanosuspension are discussed briefly. This patent-based review will enhance the knowledge of control drug delivery and related patents on nanosuspension.

Keywords: Nanosuspension, supercritical fluid method, high-pressure homogenization, nanojet, patent, hydrosol, precipitation method.

« Previous
Graphical Abstract

[1]
Verma R, Kaushik D. Design and optimization of candesartan loaded self-nanoemulsifying drug delivery system for improving its dissolution rate and pharmacodynamic potential. Drug Deliv 2020; 27(1): 756-71.
[http://dx.doi.org/10.1080/10717544.2020.1760961 ] [PMID: 32397771]
[2]
Shid RL, Dhole SN, Kulkarni N, Shid SL. Nanosuspension: A review. Int J Pharm Sci Rev Res 2013; 22(1): 98-106.
[3]
Chaudhary SK, Nina M, Rao PB, Chakraborty J. Acelofenac nanosuspension: Formulation and evaluation. Uni Int J Pharm Bio Sci 2016; 4(02): 11-9.
[4]
Verma R, Kaushik D. Development, optimization, characterization and impact of in vitro lipolysis on drug release of telmisartan loaded SMEDDS. Drug Deliv Lett 2019; 9(4): 330-40.
[http://dx.doi.org/10.2174/2210303109666190614120556]
[5]
Verma R, Mittal V, Pandey P, et al. Exploring the role of self-nanoemulsifying systems in drug delivery: Challenges, issues, applications and recent advances. Curr Drug Deliv 2023; 20(9): 1241-61.
[http://dx.doi.org/10.2174/1567201819666220519125003 ] [PMID: 35598245]
[6]
Verma R, Mittal V, Kaushik D. Self-microemulsifying drug delivery system: A vital approach for bioavailability enhancement. Int J Chemtech Res 2017; 10(7): 515-28.
[7]
Kaushik R, Budhwar V, Kaushik D. An overview on recent patents and technologies on solid dispersion. Recent Pat Drug Deliv Formul 2020; 14(1): 63-74.
[http://dx.doi.org/10.2174/22124039MTAzoNzEwy ] [PMID: 31951172]
[8]
Nakarani M, Misra AK, Patel JK, Vaghani SS. Itraconazole nanosuspension for oral delivery: Formulation, characterization and in vitro comparison with marketed formulation. Daru 2010; 18(2): 84-90.
[PMID: 22615599]
[9]
Kabir MT, Rahman MH, Akter R, et al. Potential role of curcumin and its nanoformulations to treat various types of cancers. Biomolecules 2021; 11(3): 392.
[http://dx.doi.org/10.3390/biom11030392] [PMID: 33800000]
[10]
Devi S, Kumar S, Verma V, Kaushik D, Verma R, Bhatia M. Enhancement of ketoprofen dissolution rate by the liquisolid technique: optimization and in vitro and in vivo investigations. Drug Deliv Transl Res 2022; 12(11): 2693-707.
[http://dx.doi.org/10.1007/s13346-022-01120-x] [PMID: 35178670]
[11]
Kaushik D, Goel E, Verma R, et al. An overview of recent patents and patented technology platforms based on co-processed excipients. Recent Advances in Drug Delivery and Formulation 2021; 15(1): 3-14.
[http://dx.doi.org/10.2174/1872211314999210104211125 ] [PMID: 33397276]
[12]
Kumar MS. Formulation and evaluation of albendazole nanosuspension. Int J Pharm Anal Res 2018; 7(2): 201-15.
[13]
Dutt R, Kaushik D, Sinha S, et al. Development of biocompatible nanoparticles of tizanidine hydrochloride in orodispersible films: in vitro characterization, ex vivo permeation, and cytotoxic study on carcinoma cells. Curr Drug Deliv 2022; 19(10): 1061-72.
[http://dx.doi.org/10.2174/1567201819666220321111338 ] [PMID: 35319369]
[14]
Tapia-Hernández JA, Rodríguez-Felix F, Juárez-Onofre JE, et al. Zein-polysaccharide nanoparticles as matrices for antioxidant compounds: A strategy for prevention of chronic degenerative diseases. Food Res Int 2018; 111: 451-71.
[http://dx.doi.org/10.1016/j.foodres.2018.05.036] [PMID: 30007708]
[15]
Rodríguez-Félix F, Del-Toro-Sánchez CL, Javier Cinco-Moroyoqui F, et al. Preparation and characterization of quercetin-loaded zein nanoparticles by electrospraying and study of in vitro bioavailability. J Food Sci 2019; 84(10): 2883-97.
[http://dx.doi.org/10.1111/1750-3841.14803] [PMID: 31553062]
[16]
Rani A, Verma R, Mittal V, et al. Formulation development and optimization of rosuvastatin loaded nanosuspension for enhancing dissolution rate. Curr Drug ther 2023; 18(1): 75-87.
[http://dx.doi.org/10.2174/1574885517666220822104652]
[17]
Tapia-Hernández JA, Del-Toro-Sánchez CL, Cinco-Moroyoqui FJ, et al. Gallic acid-loaded zein nanoparticles by electrospraying process. J Food Sci 2019; 84(4): 818-31.
[http://dx.doi.org/10.1111/1750-3841.14486] [PMID: 30802954]
[18]
Goel S, Sachdeva M, Agarwal V. Nanosuspension technology: Recent patent on drug delivery and their characterization. Recent Pat Drug Deliv Formul 2019; 13(2): 91-104.
[http://dx.doi.org/10.2174/1872211313666190614151615 ] [PMID: 31203813]
[19]
Kavitha VB, Neethu CS, Kumar BD, Kumar KK, John A. Nanosuspension: An overview Nanosci Nanotech. Int J 2014; 4(1): 1-5.
[20]
Tapia-Hernández JA, Del-Toro-Sánchez CL, Cinco-Moroyoqui FJ, et al. Prolamins from cereal by-products: Classification, extraction, characterization and its applications in micro- and nanofabrication. Trends Food Sci Technol 2019; 90: 111-32.
[http://dx.doi.org/10.1016/j.tifs.2019.06.005]
[21]
Singh VK, Chandra D, Singh P, Kumar S, Singh AP. Nanosuspension: Way to enhance the bioavailability of poorly soluble drug. Int J Current Trends Pharm Res 2013; 1(4): 277-87.
[22]
Gharge VS, Shinde MB, Pustake BD, Kinage KB, Kulkarni AA. Nanosuspension: Recent patent and pharmaceutical aspects as drug delivery system. Intl J Pharmaceut Sci Nanotech 2017; 10(2): 3631-44.
[http://dx.doi.org/10.37285/ijpsn.2017.10.2.1]
[23]
Yadav GV, Singh SR. Nanosuspension: A promising drug delivery system. An Int Res J 2012; 3(5): 217-43.
[24]
Luo R, Zhnag Z. Felodipine nanosuspension and preparation method thereof. CN103251557A, 2016.
[25]
Pavlos P, Gerhard R, Mark JD, James EK, Berthold R. Nanosuspension compositions of tubulin inhibitor compounds. US2014212495A1, 2014.
[26]
Alexey P, Elizabeth ME, Hongming C, James B. Compositions and methods for ophthalmic and or other applications. US9827191B2, 2017.
[27]
Runtfeld C, Stecked H, Sherley H, Shirift HL. Nanosuspension with antifungal drug administration by inhalation with improved impurity profile and safety. JP2011513258A, 2011.
[28]
Lin Z, Shinde W, Zhaoming L. Prepration method of celecoxib nanosuspension capsules. CN105534947A, 2016.
[29]
Gregoire L, Maris MF, Alexandre M, Smita D. Nystatin nanosuspension formulation using high pressure homogenization. CA2946982A1, 2016.
[30]
Rolf P. Nanocrystal for use in topical cosmetic formulation and method of production thereof. CA2669392C, 2016.
[31]
Xinghao Y, Sun J, Yang T. A kind of preparation method and application of chitosan nanosuspension. CN105001433B, 2018.
[32]
Zhang J, Wu X. Lurasidone nanosuspension and preparation method thereof. CN10481926A2015,
[33]
Zhang L, Wu S, Li Z, Dong S, Feng J, Sun E, et al. Prepration method of celecoxib nanosuspension capsules 2016. Patent CN105534947A,
[34]
Bhowmik D, Harish G, Duraivel S, Kumar BP, Raghuvanshi V, Kumar KP. A novel approaches in drug delivery system. Pharm Innov J 2013; 1(12): 50-63.
[35]
Sonke S, Chris T, Steve L, Jonathan E, Steve R. Drug nanoparticle from template emulsion. US20030133987A1, 2003.
[36]
Shlomo M, Hadas N, Katrin G. Organic nanoparticles obtain from microemulsion by solvent. US20110021592A, 2011.
[37]
Sung JH, Min SK, Jeong SK, Kwang HC, Jun SP, Won KC, et al. Manufacturing method and apparatus of ultrafine particles having uniform particle size. US8734830B2, 2014.
[38]
Aron D, Felix M, Mark N, Adrian R, William HB. Formulation of indomethacin. US10172828B2, 2019.
[39]
Tapia-Hernández JA, Torres-Chávez PI, Ramírez-Wong B, et al. Micro- and nanoparticles by electrospray: advances and applications in foods. J Agric Food Chem 2015; 63(19): 4699-707.
[http://dx.doi.org/10.1021/acs.jafc.5b01403] [PMID: 25938374]
[40]
Tapia-Hernández JA, Rodríguez-Félix DE, Plascencia-Jatomea M, et al. Porous wheat gluten microparticles obtained by electrospray: Preparation and characterization. Adv Polym Technol 2018; 37(6): 2314-24.
[http://dx.doi.org/10.1002/adv.21907]
[41]
Tapia-Hernández JA, Rodríguez-Félix F, Katouzian I. Nanocapsule formation by electrospraying. In: Nanoencapsulation technologies for the food and nutraceutical industries. Academic Press 2023; pp. 320-45.
[42]
Paximada P, Howarth M, Dubey B. Electrosprayed particles derived from nanoemulsions as a carrier of fish oil. TechConnect Briefs 2018.
[43]
Garasiya SB. Nanosuspension: An attempt to enhance bioavailability of poorly soluble drugs. Int J Adv Pharma Bio Chem 2012; 1(1): 91-9.
[44]
Reddy MS, Sreeramulu J, Reddy YN, Rammohan G. Formulation and evaluation of telmisartan nanosuspension. Int J Res Pharm Chem 2018; 8(4): 572-6.
[45]
Pardeep KM, Chandrasekhar KB. Formulation and in vitro and in vitro characterization of nifedipine stabilized nanosuspension by nanoprecipitation method. Int J Res Pharma Sci 2017; 8(4): 759-66.
[46]
Kaseem MA, Elmeshad AN, Fares AR. Enhanced solubility and dissolution rate of lacidipine nanosuspension: Formulation via antisolvent sonoprecipitation technique and optimization using box–behnken design. AAPS Pharm SciTech 2017; 18(4): 983-96.
[http://dx.doi.org/10.1208/s12249-016-0604-1]
[47]
Gera S, Talluri S, Rangaraj N, Sampathi S. Formulation and evaluation of naringenin nanosuspension for bioavailability enhancement. AAPS Pharm SciTech 2017; 18(8): 3151-62.
[http://dx.doi.org/10.1208/s12249-017-0790-5]
[48]
Sahu BP, Das MK. Nanosuspension for enhancement of oral bioavailability of felodipine. Appl Nanosci 2014; 4(2): 189-97.
[http://dx.doi.org/10.1007/s13204-012-0188-3]
[49]
Sattar A, Chen D, Jiang L, et al. Preparation, characterization and pharmacokinetics of cyadox nanosuspension. Sci Rep 2017; 7(1): 2289-96.
[http://dx.doi.org/10.1038/s41598-017-02523-4] [PMID: 28536446]
[50]
Pınar S, Çelebi N. Optimization and evaluation of cyclosporine A nanosuspension stabilized by combination stabilizers using high pressure homogenization method. J Res Pharm 2019; 23(6): 1009-21.
[51]
Karadag A, Ozcelik B, Huang Q. Quercetin nanosuspensions produced by high-pressure homogenization. J Agric Food Chem 2014; 62(8): 1852-9.
[http://dx.doi.org/10.1021/jf404065p] [PMID: 24471519]
[52]
Sun W, Mao S, Shi Y, Li LC, Fang L. Nanonization of itraconazole by high pressure homogenization: stabilizer optimization and effect of particle size on oral absorption. J Pharm Sci 2011; 100(8): 3365-73.
[http://dx.doi.org/10.1002/jps.22587] [PMID: 21520089]
[53]
Qian YS, Kumar RH, Meka VS, Dharmalingam SR. Preparing kaempferol nanosuspension using high pressure homogenization technique. BMC Proc 2015; 9(S7): A22.
[http://dx.doi.org/10.1186/1753-6561-9-S7-A22]
[54]
Md S, Kit B, Jagdish S, David D, Pandey M, Chatterjee L. Development and in vitro evaluation of a zerumbone loaded nanosuspension drug delivery system. Crystals (Basel) 2018; 8(7): 286-99.
[http://dx.doi.org/10.3390/cryst8070286]
[55]
Tseng Y-C, Kanthamneni N, Valiveti S, Patel M, Xia H. Enhanced bioavailability of danazol nanosuspensions by wet milling and high-pressure homogenization. Int J Pharm Investig 2016; 6(4): 218-24.
[http://dx.doi.org/10.4103/2230-973X.195931] [PMID: 28123991]
[56]
Mokale V, Patil K, Sutar Y, Khatik T. Glyburide nanosuspension: Influence of processing and formulation parameter on solubility and in vitro dissolution behavior. Asian J Pharm 2013; 7(3): 111-7.
[http://dx.doi.org/10.4103/0973-8398.120085]
[57]
He J, Han Y, Xu G, Yin L, Neubi MN, Zhou J. Prepration and evaluation of celecoxib nanosuspension for biovailability enhancement. RSC Advances 2017; 7: 1353-64.
[58]
Fülöp V, Jakab G, Bozó T, et al. Study on the dissolution improvement of albendazole using reconstitutable dry nanosuspension formulation. Eur J Pharm Sci 2018; 123: 70-8.
[http://dx.doi.org/10.1016/j.ejps.2018.07.027] [PMID: 30010031]
[59]
Detroja C, Chavhan S, Sawant K. Enhanced antihypertensive activity of candesartan cilexetil nanosuspension: formulation, characterization and pharmacodynamic study. Sci Pharm 2011; 79(3): 635-51.
[http://dx.doi.org/10.3797/scipharm.1103-17] [PMID: 21886909]
[60]
Jethara SI, Patel AD, Patel MR, Patel MS, Patel KR. Recent survey on nanosuspension: a patent overview. Rec Patents Drug Dev Formula 2015; 9(1): 65-78.
[http://dx.doi.org/10.2174/1872211308666141028214003 ] [PMID: 25354346]
[61]
Mane AN, Gilda SS, Ghadge AA, Bhosekar NR, Bhosale RR. Nanosuspension: A novel carrier for lipidic drug transfer. Sch Acad J Pharm 2014; 3(1): 82-8.
[62]
Gary GL, Kenneth CC. Particle size reduction for improvement of oral bioavailability of hydrophobic drug: Absolute oral bioavailability of nanocrystalline donazole nanosuspension in beagle dogs. Int J Pharm 1995; 125: 91-7.
[http://dx.doi.org/10.1016/0378-5173(95)00122-Y]
[63]
Kayser O, Olbrich C, Yardley V, Kiderlen AF, Croft SL. Formulation of amphotericin B as nanosuspension for oral administration. Int J Pharm 2003; 254(1): 73-5.
[http://dx.doi.org/10.1016/S0378-5173(02)00686-5 ] [PMID: 12615413]
[64]
Kassem M, Abdelrahman A, Ghorab M, Ahmed M, Khalil R. Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs. Int J Pharm 2007; 340(1-2): 126-33.
[http://dx.doi.org/10.1016/j.ijpharm.2007.03.011] [PMID: 17600645]
[65]
Manisk K, Nithya S, Arun KM, Shashank S, Rajnikanth PS. Preparation of luliconazole nanosrystal loaded hydrogel for improvement of dissolution and antifungal activity. J Homepage 2019; 5: 65-8.
[66]
Jagtiani AV, Carletta J, Zhe J. An impedimetric approach for accurate particle sizing using a microfluidic Coulter counter. J Micromech Microeng 2011; 21(4): 045036.
[http://dx.doi.org/10.1088/0960-1317/21/4/045036]
[67]
Gill P, Moghadam TT, Ranjbar B. Differential scanning calorimetry techniques: applications in biology and nanoscience. J Biomol Tech 2010; 21(4): 167-93.
[PMID: 21119929]
[68]
High-drug-loading breviscapine porous spherulites and preparation method thereof. CN116570568A, 2023.
[69]
Liquid metal conductive nano-particle and preparation method and application thereof CN116550968A, 2023.
[70]
Organosilicon nano composite emulsion and preparation method and application thereof. CN116515298A, 2023.
[71]
Anti-tumor nano slow release agent and preparation method and application thereof. CN116271099A, 2023.
[72]
High-bioavailability telavancin dry suspension and preparation method thereof. CN116407505A, 2023.
[73]
Granules comprising progerinin, and sachets using same. WO2023146211A1, 2023.
[74]
Ong WZ, Nowak PW, Kim J, et al. Meropenem derivatives and uses thereof. US20200010470, 2010.
[75]
Ensign L, Hanes J, Date A, Bivalacqua T, Kates M. Nanoparticle formulation for enhanced drug delivery to the bladder. US20200009068, 2020.
[76]
Hanes J, Ensign LM. Mucus penetrating budesonide nanosuspension on enema for local treatment of inflammatory bowel disease. US20190015349, 2019.
[77]
Goyal V, Patel G. Compositions for preventing and relieving hangover and liver damage which occur due to alcohol consumption. US20190314298, 2019.
[78]
Inghelbrechi SKK, Beirowski JA, Gieseler H. Freeze dried drug nanosuspension. US20190076428, 2019.
[79]
Moroz JBA, Okuda JCY, Cerize NNP, et al. A process for producing a thermofunctional nanostructure obtained via polymerization in emulsion. US20190031936, 2019.
[80]
Kaytor MD, Zenk JK. Method of mitigating long and short term detrimental effects of exposure to low dose ionizing radiation by administration of genistein. US20180256535, 2018.
[81]
Bommagani M, Bhowmick SB, Kane P, Dubey V. Method of preparing nanoparticulate topical composition. US20180235983, 2018.
[82]
Zhang Z, Mortenson MG. Methods and treatment for certain demyelination based disorders and/ or promoting remyelination. US20180228838, 2018.
[83]
Mallard C, Djedour AS. Compositions comprising water dispersible nanoparticles of retinoid compound. US20180185329, 2018.
[84]
Mao S, Guan J, Helgerud J, Zhang Y. Nanosuspension formulation. US20180250227, 2018.
[85]
James D, Rupert O, Diane O, Gerold L. Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid. EP172512B1, 2017.
[86]
Xiang W, Yang C, Liangyu Z. Camptothecin nano-gel. CN104490764B, 2017.
[87]
Bahl D, Crowely KJ, Yu D. Oral solid dosage form containing nanoparticles and process of formulating the same using fish gelatin. US9775819B2, 2017.
[88]
Mingbao Z, Raymond G, David C. Injectable neurosteroid formulations containing nanoparticles. WO2017/066626A1, 2017.
[89]
Liangzhu C, Binghu F, Zhikun P, Ming C, Pengling Y. A kind of enrofloxacin nanosuspension and preparation method thereof. CN106265504A, 2016.
[90]
Qiang F, Jin S, Yanxian H, Masu Y, Wenqian Y, Zhonggui H. A kind of processing method of nanosuspension solidification process. CN105902496B, 2016.
[91]
Ruixue L, Zhenhai Z. A kind of fenofibrate nanometer suspension and preparation method thereof. CN103239401B, 2016.
[92]
Chengsheng L, Yaxuan W. Megestrol acetate nanosuspension, preparation method and application thereof. CN105769763A, 2016.
[93]
Bai W, Mengmeng L. Brain targeting nimodipine nanosuspension and preparation method thereof. CN105596293A, 2016.
[94]
Xiaoying D, Minki M, Yihual L, et al. A kind of long acting composite sulfamonomethoxine nanosuspension and preparation method thereof. CN1041611724B, 2016.

Rights & Permissions Print Cite
Article Metrics
15
2
Wayfinder Image
© 2024 Bentham Science Publishers | Privacy Policy